| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.0M | — |
| R&D Expense | $7.8M | +94.7% |
| SG&A Expense | $5.5M | +18.9% |
| Operating Income | $4.5M | +135.8% |
| Pre-tax Income | $5.7M | +145.6% |
| Income Tax | $2.1M | +2186.3% |
| Net Income | $3.6M | +128.7% |
| EPS (Basic) | $0.93 | +134.6% |
| EPS (Diluted) | $0.87 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.8M | +54.5% |
| Short-term Investments | $23.0M | — |
| Accounts Receivable | $601K | — |
| Current Assets | $29.7M | +527.0% |
| Total Assets | $36.5M | +166.1% |
| Current Liabilities | $6.0M | +267.7% |
| Total Liabilities | $10.7M | +41.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $8.6M | +189.6% |
| Capital Expenditures | $6K | — |
| Investing Cash Flow | -$22.7M | — |
| Financing Cash Flow | $15.5M | +159.8% |
| Free Cash Flow | $8.6M | +189.5% |
| +132.3% |
| Stockholders' Equity |
| $25.8M |
| +321.6% |